I can only assume it means that it is "a safe and active dose" for cancer, but is that the same for a patient with CoVID? I guess they need to be very confident. Last thing we need a catastrophic CoVID patient outcome that casts a dark shadow over our very promising Cancer patient treatment.
I agree that sounds like a very low risk, but for us that could be a very high consequence.
I like that they are being professional, my only beef is I'd like to know more about the road map and milestones. That said their strategy is clearly to do good science, meet their ASX obligations and quietly land a great deal with VM - due anytime soon imo as every day without a deal is lost revenue for all.
Regards
Covi-Pantel . NZ Trader Release, page-18
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.025(13.5%) |
Mkt cap ! $83.14M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 22.0¢ | 20.0¢ | $733.4K | 3.538M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 113800 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 240088 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.025 ( 13.5 %) |
||||
| Open | High | Low | Volume | ||
| 20.5¢ | 22.0¢ | 20.0¢ | 1388603 | ||
| Last updated 15.56pm 31/05/2024 ? | |||||
| PAA (ASX) Chart |